Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/6534
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2022-04-19T17:50:03Z-
dc.date.available2022-04-19T17:50:03Z-
dc.date.issued2021-03-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/6534-
dc.language.isootherpt_BR
dc.publisherINCApt_BR
dc.subjectVacinas contra COVID-19pt_BR
dc.subjectCOVID-19 Vaccinespt_BR
dc.subjectVacunas contra la COVID-19pt_BR
dc.subjectVacinaspt_BR
dc.subjectVaccinespt_BR
dc.subjectVacunaspt_BR
dc.subjectKalil Filho, Jorge Eliaspt_BR
dc.titleCiclo de palestras aborda produção de vacinas contra Covid-19pt_BR
dc.title.alternativeInforme INCA 405pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 405

Files in This Item:
File Description SizeFormat 
Informe-INCA-2021-405-8-Ciclo-de-palestras.pdf298.27 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.